A STABILITY-INDICATING HPLC METHOD FOR THE DETERMINATION OF POTENTIAL IMPURITIES IN A NEW FIXED DOSE COMBINATION OF DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS USED IN THE FIRST LINE TREATMENT OF HIV-1 INFECTION. International Research Journal of Pharmacy, [S. l.], v. 9, n. 5, p. 90–99, 2018. Disponível em: https://irjponline.org/index.php/irjp/article/view/1071. Acesso em: 3 nov. 2026.